Cargando…
Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports
Background Although indomethacin (IND) is the standard treatment for hemodynamically significant patent ductus arteriosus (hsPDA) in Japan, it may be associated with renal impairment and gastrointestinal complications. The use of paracetamol for hsPDA closure has recently increased. Unlike IND, par...
Autores principales: | Matsumura, Shun, Oshima, Ayumi, Fujinuma, Sumie, Tanaka, Kosuke, Nagano, Nobuhiko, Miyake, Fuyu, Masutani, Satoshi, Tamura, Masanori, Ueda, Keiko, Namba, Fumihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740229/ https://www.ncbi.nlm.nih.gov/pubmed/29276647 http://dx.doi.org/10.1055/s-0037-1615260 |
Ejemplares similares
-
Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series
por: Oshima, Ayumi, et al.
Publicado: (2020) -
Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?
por: Bardanzellu, Flaminia, et al.
Publicado: (2017) -
iPAPP: study protocol for a multicentre randomised controlled trial comparing safety and efficacy of intravenous paracetamol and indomethacin for the treatment of patent ductus arteriosus in preterm infants
por: Namba, Fumihiko, et al.
Publicado: (2023) -
Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates
por: Terrin, Gianluca, et al.
Publicado: (2014) -
Comparison of the efficacy and safety of indomethacin, ibuprofen, and paracetamol in the closure of patent ductus arteriosus in preterm neonates – A randomized controlled trial
por: Meena, Vasudha, et al.
Publicado: (2020)